Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
Anticorpi anti virus Epstein-Barr (EBV) - Analisi Papagni
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
a) eBV seropositivity rates by age cohorts in a large hospital... | Download Scientific Diagram
A scheme of serological response to Epstein-Barr virus (EBV)... | Download Scientific Diagram
Frontiers | Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect
VIRUS EPSTEIN-BARR (VCA IgG) - Analisi Papagni
Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
Positive Correlation between Epstein-Barr Virus Viral Load and Anti-Viral Capsid Immunoglobulin G Titers Determined for Hodgkin's Lymphoma Patients and Their Relatives | Journal of Clinical Microbiology
Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. - Abstract - Europe PMC
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations | ACS Chemical Neuroscience
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls | HTML
Levels of Antibodies Specific to Epstein-Barr Virus (EBV) during... | Download Scientific Diagram